The growing prevalence of chronic diseases is a major factor driving revenue growth in the natural killer (NK) cell ...

Hangzhou Qihan Biotech Co., Ltd. ("Qihan" or "Qihan Biotech" or "the Company"), an industry leader in applying multiplexable genome editing technology to cell therapies and organ transplantation, ...

Malaria is a life-threatening disease affecting people globally. It is spread by mosquitoes carrying Plasmodium parasites ...

Researchers from The University of Osaka found that both inhibitory and activating killer immunoglobulin-like receptors on ...

Researchers at the VIB-KU Leuven Center for Cancer Biology have uncovered that "natural killer" cells (NK), a type of immune cell, may actually be hindering the immune system's ability to attack ...

LONDON, GREATER LONDON, UNITED KINGDOM, June 20, 2025 /EINPresswire.com/ -- The Business Research Company’s latest report explores market drivers, trends, regional insights, and provides market sizing ...

Dupilumab use in asthma linked to higher lymphoma risk, especially T/NK cell types, though overall mortality was lower, new ...

The field of cellular immunotherapy has undergone a profound transformation in recent years, with autologous chimeric antigen receptor (CAR) T-cell therapies emerging as the standard-of-care option ...

NKGen Biotech has activated two new trial sites in Canada and Florida for the Phase I/IIa study of troculeucel to treat ...

Natural killer (NK) cells are critical innate immune effector cells but during chronic inflammatory contexts their function and fitness may become impaired. Here the authors implicate the cytokine ...

A novel chimeric antigen receptor T-cell therapy may benefit patients with B-cell lymphomas who previously relapsed following ...